I

ImmunityBio, Inc.

562 employees

ImmunityBio is a late-stage immunotherapy startup that is developing treatments to drive immunogenic pathways in the fight against cancer.

Basic info

Industry

biotechnology research

Sectors

Yeast
Oncology
Vaccine
Cell Therapy
Vaccines
Clinical Trials
COVID-19
Health Diagnostics
Health Care
T Cell
Immunotherapy
Therapeutics
Fusion Proteins
Infectious Diseases
Manufacturing
Natural Killer
Cancer

Date founded

2014

FAQ